申请人:BioChem Pharma Inc.
公开号:US20020099072A1
公开(公告)日:2002-07-25
The present invention is concerned with novel [1,8] naphthyridine derivatives useful for the inhibition of the hepatitis virus, more specifically the hepatitis C virus.
本发明涉及新型[1,8]萘啶衍生物,可用于抑制肝炎病毒,特别是丙型肝炎病毒。